Similarly, we found a stop-gain variant in PPT1 (p.R48X) in an early onset (61 years) familial AD patient; PPT1 loss of function mutations have been previously demonstrated to cause an adult form of neuronal ceroid lipofuscinosis (NCL) [30,31]. Here, PPT1 is linked to infantile neuronal ceroid lipofuscinosis.